Grantek’s Bryon Hayes Writes About Using Technology for Continuous Process Verification 4.0 in ISPE’s “Pharmaceutical Engineering”
January 17, 2023
The January/February 2023 issue of ISPE’s (International Society for Pharmaceutical Engineering) Pharmaceutical Engineering features an article which reviews using technology for continuous process verification 4.0. Grantek’s Director of Smart Manufacturing Solutions, Bryon Hayes, co-wrote this article.
“In this article, potential Pharma 4.0™ technological solutions that can enhance continuous process verification (CPV) 4.0 are discussed. The necessary paradigm shift will allow companies to predict deviations more accurately, perform root cause analysis (RCA), ensure data integrity and GxP compliance, and ultimately be more competitive in a highly regulated industry.”
– ISPE’s Pharmaceutical Engineering, January/February 2023
Bryon was recently appointed to the ISPE Canada Affiliate Board of Directors for 2023-2024. Bryon is a respected leader in the pharma manufacturing industry. ISPE is the global industry leader in connecting pharmaceutical knowledge to deliver manufacturing and supply chain innovation, operational excellence and regulatory insights to enhance industry efforts to develop, manufacture and reliably deliver quality medicines to patients. Bryon has 20 years of experience working within in the life sciences industry. At Grantek, he is responsible for translating current trends in the life sciences landscape into actionable technical partnership opportunities, training plans, and growth strategies. Bryon is a member of ISPE and International Society of Automation (ISA). He is on the ISPE Pharma 4.0 Special Interest Group and sits on the Impact & Maturity sub-committee.
ISPE Canada Affiliate is the leading industry association supporting Canadian pharma and biopharma manufacturing communities. The 400 Canadian members are part of a global community of 18,000 members from more than 90 countries. The Canada Affiliate and its global peers collaborate to drive innovation and lead conversations, offer new ways to serve the industry and its members, and advance solutions that improve patient health.